Zentek (CVE:ZEN) Shares Down 7.8% – Should You Sell?

Zentek Ltd. (CVE:ZENGet Free Report)’s share price fell 7.8% during trading on Monday . The company traded as low as C$0.61 and last traded at C$0.71. 258,275 shares changed hands during mid-day trading, an increase of 69% from the average session volume of 153,260 shares. The stock had previously closed at C$0.77.

Zentek Trading Down 7.8%

The firm has a market cap of C$89.90 million, a P/E ratio of -7.32 and a beta of 0.72. The business’s 50-day moving average is C$0.76 and its two-hundred day moving average is C$0.78. The company has a current ratio of 4.65, a quick ratio of 7.59 and a debt-to-equity ratio of 7.62.

About Zentek

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.

Featured Articles

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.